SPEARHEAD
Consortium

The University of Basel is the oldest university in Switzerland. It works closely with national and international partners to advance sciences and society. The Innovation Office is the university’s hub for entrepreneurship and innovation turning cutting-edge research into ventures.
The European Center of Pharmaceutical Medicine (ECPM) is a leading university institute for medicines and drug development in Europe. It focuses on education and dedicated training programs for drug development specialists.
The University Hospital Basel brings together 50 clinics, units and institutes. It  conducts research and innovation for the benefit of patients. It has seven interdisciplinary areas of clinical, research and development focus to advance the progress in medicine.

The University Children’s Hospital Basel (UKBB) offers comprehensive medical, nursing and therapeutic care for children and adolescents. It has long standing clinical expertise in microbiology and AMR diagnosis, as well as in clinical management of AMRs and AMR therapy stewardship.

The Institute of Design (IDe) of the University of Applied Sciences and Arts of Southern Switzerland is a research center focusing on cutting-edge and emerging design practices, critically reflecting on the user experiences, behaviors, aesthetics, spaces and technologies, with a particular emphasis on open innovation for social and cultural development. SUPSI FabLab is the laboratory of digital fabrication and open innovation that supports the digital skills development in the sector of architecture, design and creative technologies.

SUPSI IDSIA is a joint institute of both the Faculty of Informatics of the Università della Svizzera italiana (USI) and the Department of Innovative Technologies of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI). It is focused on AI studies, machine learning, operations research, data mining, and robotics.

The Geneva University Hospitals (HUG) are the largest university hospital in Switzerland, regrouping 8 public hospitals in Geneva, 2 clinics and 30 outpatient clinics throughout the canton of Geneva. HUG’s work focuses on cutting-edge medicine in various disease areas.

The Centre Hospitalier Universitaire Vaudois (CHUV) is linked to the Faculty of Biology and Medicine of the University of Lausanne, and plays a leading role in the fields of medical care, medical research and education.

Resistell is a clinical stage medtech start-up developing the world’s fastest Antibiotic Susceptibility Test (AST) for bloodstream and urinary tract infections, using a groundbreaking nanomotion technology.

WAAT Switzerland is a cross-functional digital agency that provides public and private sector organizations with the enterprise-level digital solutions required to deliver their innovation projects.

Swiss Re Group is one of the world’s leading providers of reinsurance, insurance and other forms of insurance-based risk transfer, working to make the world more resilient. It anticipates and manages risk – from natural catastrophes to climate change, from aging populations to cybercrime.

Novartis is a worldwide leading pharmaceutical company dedicated to improve and extend people’s life in cardiovascular and metabolic diseases, oncology, immunology, and neurosciences. Novartis delivers high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

OM Pharma is a Swiss biopharmaceutical company advancing immune health through bacterial lysates, with a focus on preventing respiratory and urinary tract infections. The company also develops small molecule therapies for vascular diseases and continues to explore new indications and formulations in immunology.

SWICA is one of the leading health and accident insurers in Switzerland. It offers long-term financial security and optimum medical care in the event of illness, accident and maternity.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit global health organization driven to protect people from the rise and spread of drug-resistant infections. It accelerates the development and access of treatments for drug-resistant bacterial infections.

The National Center of Competence in Research (NCCR) AntiResist aims to tackle the rapid and global rise and spread of antibiotic resistance. It is a group of experts in the fields of clinical research, infection biology, chemistry, computation, engineering and pharmacology advancing the research in antimicrobial resistance.